Literature DB >> 2114216

Investigation of cytokine gene expression in human colorectal cancer.

M S Naylor1, G W Stamp, F R Balkwill.   

Abstract

RNA was extracted from 28 samples of colorectal cancer and 26 samples of adjacent normal bowel. Northern blotting analysis showed the presence of mRNA for tumor necrosis factor (TNF) in 15 of 28 cancer samples and 6 of 26 matched normal areas. In 10 patients, TNF mRNA was found only in the tumor; in 5, TNF mRNA was seen in tumor and normal areas; and in only 1 was TNF mRNA seen in the normal, but not the malignant, area. The expression of TNF mRNA was not related to the stage of disease, degree of lymphocyte infiltration, or necrosis in the tumor. Blots were reprobed for gamma-interferon, interleukin (IL) 1 alpha and beta, IL-6, and transforming growth factor beta 1 mRNA. One tumor sample was positive for IL-1 beta, and one normal sample expressed interferon gamma mRNA. All samples had transforming growth factor beta 1 mRNA, and there was no obvious difference between levels in tumor tissues or adjacent normal areas. In situ hybridization studies with a TNF riboprobe showed that TNF mRNA was only detectable in a small minority of mononuclear and predominantly stromal cells. Immunohistochemistry on sequential sections showed that CD4- and CD8-positive lymphocytes, and macrophages, were present in the stroma. An antibody to the macrophage C3b receptor identified a minority population whose distribution corresponded closely to the cells labeled with the TNF riboprobe.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2114216

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  19 in total

1.  Evaluation of serum levels of tumour necrosis factor-alpha (TNF-alpha) and soluble IL-2 receptor (sIL-2R) and CD4, CD8 and natural killer (NK) populations during infrared pulsed laser device (IPLD) treatment.

Authors:  L A Santana-Blank; M Castes; M E Rojas; F Vargas; D Scott-Algara
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

2.  Antioxidants inhibit TNFalpha-induced motility and invasion of human osteosarcoma cells: possible involvement of NFkappaB activation.

Authors:  K Harimaya; K Tanaka; Y Matsumoto; H Sato; S Matsuda; Y Iwamoto
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

3.  Profiling lipoxygenase metabolism in specific steps of colorectal tumorigenesis.

Authors:  Imad Shureiqi; Dongning Chen; R Sue Day; Xiangsheng Zuo; Fredric Lyone Hochman; William A Ross; Rhonda A Cole; Ofie Moy; Jeffrey S Morris; Lianchun Xiao; Robert A Newman; Peiying Yang; Scott M Lippman
Journal:  Cancer Prev Res (Phila)       Date:  2010-06-22

4.  Inhibition of colon cancer growth by docosahexaenoic acid involves autocrine production of TNFα.

Authors:  A Fluckiger; A Dumont; V Derangère; C Rébé; C de Rosny; S Causse; C Thomas; L Apetoh; A Hichami; F Ghiringhelli; M Rialland
Journal:  Oncogene       Date:  2016-02-08       Impact factor: 9.867

5.  Association of -308G/A and -238G/A polymorphisms of TNF-α and osteosarcoma risk.

Authors:  Zhongwei Zhao; Xiangyu Tang; Kai Song; Xiang Li; Yonggang Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

Review 6.  Are cytokines possible mediators of cancer cachexia?

Authors:  Y Noguchi; T Yoshikawa; A Matsumoto; G Svaninger; J Gelin
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

7.  Expression of cytokine mRNA in human melanoma tissues.

Authors:  E C Lattime; M J Mastrangelo; O Bagasra; W Li; D Berd
Journal:  Cancer Immunol Immunother       Date:  1995-09       Impact factor: 6.968

8.  TNF-α expression, risk factors, and inflammatory exposures in ovarian cancer: evidence for an inflammatory pathway of ovarian carcinogenesis?

Authors:  Mamta Gupta; Ana Babic; Andrew H Beck; Kathryn Terry
Journal:  Hum Pathol       Date:  2016-04-08       Impact factor: 3.466

9.  Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression.

Authors:  M S Naylor; G W Stamp; W D Foulkes; D Eccles; F R Balkwill
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

10.  The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer.

Authors:  R P Negus; G W Stamp; M G Relf; F Burke; S T Malik; S Bernasconi; P Allavena; S Sozzani; A Mantovani; F R Balkwill
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.